CSL shares have fallen almost 40% in 2025. Investors are now asking if the worst is already behind the stock. The post Will ...

CSL management originally forecast revenue growth of 4-5% and net profit after tax before amortisation (NPATA) growth of 7-10 ...

CSL is a century-old company and a darling among healthcare stocks, having delivered a 15% annual return over the past 10 years. Yet investors are spooked; the stock is down 12% since we upgraded CSL ...

Steven Ewing spent his childhood reading car magazines, making his career as an automotive journalist an absolute dream job. After getting his foot in the door at Automobile while he was still a ...

With plasma collection as its stock-in-trade, the struggles of CSL during the coronavirus lockdown were understandable. But a rebound—fueled by a surge in post-pandemic collections and an $11.7 ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...

We had reports that a beastly new CSL edition of the BMW M4 would arrive this May. It’s now May, and BMW has just unleashed a new M4 CSL, a car that — at least on paper — may lay claim to the crown as ...

After an antitrust review knocked 2021’s biggest biopharma buyout off course in May, CSL’s $11.7 billion deal for Swiss iron deficiency specialist Vifor Pharma appears to be back on track. Tuesday, ...

BMW has brought back the 3.0 CSL name on a new limited-edition sports car that echoes the design of the original '70s-era 3.0 CSL and sports a motorsports-inspired livery. The twin-turbo 3.0-liter ...

Of all the performance suffixes you can attach to a BMW, CSL (short for Competition Sport Lightweight) may just be the one that creates the highest of expectations. Hopefully, BMW has brought its ...

CSL Behring’s largest-ever trial has ended in failure, as the Australian pharma revealed that its cholesterol efflux enhancer was unable to reduce the risk of heart attacks. The company had been ...